Yoko Takahashi Selected Research

Yoko Takahashi Research Topics

Disease

28	Neoplasms (Cancer) 04/2024 - 01/2002
9	Neoplasm Metastasis (Metastasis) 08/2023 - 01/2002
8	Breast Neoplasms (Breast Cancer) 06/2023 - 07/2008
5	Stroke (Strokes) 01/2023 - 01/2018
5	Prostatic Neoplasms (Prostate Cancer) 10/2008 - 10/2004
4	Sinonasal undifferentiated carcinoma 04/2024 - 01/2016
4	Infections 12/2016 - 01/2002
4	Wounds and Injuries (Trauma) 01/2011 - 01/2006
3	Hypoglycemia (Reactive Hypoglycemia) 04/2024 - 12/2022
3	Body Weight (Weight, Body) 02/2024 - 06/2012
3	Colorectal Neoplasms (Colorectal Cancer) 07/2023 - 06/2005
3	Lymphatic Metastasis 09/2022 - 04/2005
3	Disseminated Intravascular Coagulation 07/2021 - 09/2006
3	Squamous Cell Carcinoma of Head and Neck 12/2018 - 09/2010
3	Adenocarcinoma 01/2017 - 04/2006
2	Sepsis (Septicemia) 08/2021 - 01/2021
2	Septic Shock (Toxic Shock Syndrome) 08/2021 - 01/2021
2	Ovarian Neoplasms (Ovarian Cancer) 07/2018 - 07/2011
2	Adenoma (Adenomas) 07/2018 - 10/2011
2	Hemorrhage 01/2015 - 03/2011
2	Hypertension (High Blood Pressure) 10/2013 - 06/2013
2	Edema (Dropsy) 05/2013 - 01/2012
2	Obesity 09/2012 - 01/2007
2	Lung Neoplasms (Lung Cancer) 09/2011 - 01/2002
2	Hemolysis 02/2011 - 04/2008
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 04/2024
1	Melanoma (Melanoma, Malignant) 08/2023
1	Thromboembolism 07/2023
1	Type 2 Diabetes Mellitus (MODY) 01/2023
1	Tremor (Tremors) 10/2022
1	COVID-19 01/2022
1	Olfactory Esthesioneuroblastoma (Esthesioneuroblastoma) 01/2022
1	Atrophy 03/2021
1	Cicatrix (Scar) 03/2021

Drug/Important Bio-Agent (IBA)

5	Capsules (Microcapsules)IBA 05/2013 - 01/2010
4	ErbB Receptors (EGF Receptor)IBA 07/2023 - 03/2002
4	Cisplatin (Platino)FDA LinkGeneric 12/2018 - 09/2010
4	AndrogensIBA 10/2008 - 10/2004
4	PhytochemicalsIBA 10/2008 - 10/2004
4	Proteins (Proteins, Gene)FDA Link 01/2007 - 03/2002
3	Insulin (Novolin)FDA Link 04/2024 - 04/2023
3	ChromatinIBA 03/2023 - 06/2022
3	Estrogen ReceptorsIBA 02/2023 - 06/2022
3	Dacarbazine (DIC)FDA LinkGeneric 07/2021 - 09/2006
3	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2011 - 01/2010
3	SteroidsIBA 10/2008 - 02/2004
3	GenisteinIBA 07/2008 - 10/2004
2	Hypoglycemic Agents (Hypoglycemics)IBA 04/2023 - 01/2023
2	ElementsIBA 03/2023 - 01/2023
2	Progesterone Receptors (Progesterone Receptor)IBA 02/2023 - 04/2005
2	VaccinesIBA 01/2022 - 06/2012
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2018
2	Thromboplastin (Tissue Factor)IBA 07/2021 - 10/2006
2	oxidized low density lipoproteinIBA 01/2019 - 01/2018
2	Docetaxel (Taxotere)FDA Link 12/2018 - 07/2016
2	PlasticsIBA 01/2018 - 01/2018
2	CholesterolIBA 01/2018 - 03/2008
2	Heparin (Liquaemin)FDA LinkGeneric 12/2016 - 07/2011
2	Paclitaxel (Taxol)FDA LinkGeneric 08/2015 - 07/2011
2	EnzymesIBA 06/2013 - 09/2012
2	Type III Secretion SystemsIBA 02/2011 - 04/2008
2	rebamipideIBA 01/2011 - 01/2010
2	Hormones (Hormone)IBA 10/2008 - 10/2004
2	A-Form DNA (A-DNA)IBA 07/2008 - 10/2004
2	DNA (Deoxyribonucleic Acid)IBA 12/2006 - 10/2004
2	Hemostatics (Antihemorrhagics)IBA 10/2006 - 09/2006
2	CytokinesIBA 10/2006 - 09/2006
2	LipopolysaccharidesIBA 10/2006 - 09/2006
1	Interferon-gamma (Interferon, gamma)IBA 04/2024
1	Interleukin-15 (Interleukin 15)IBA 04/2024
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 04/2024
1	Insulin Glargine (Lantus)FDA Link 02/2024
1	Immune Checkpoint InhibitorsIBA 08/2023
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2023
1	Glucagon-Like Peptide 1 (GLP 1)IBA 04/2023
1	Androgen Receptors (Androgen Receptor)IBA 02/2023
1	lixisenatideIBA 12/2022
1	Metoclopramide (Reglan)FDA LinkGeneric 10/2022
1	4-azidobenzylcarazolol (pABC)IBA 09/2022
1	TransposasesIBA 06/2022
1	Phenobarbital (Luminal)FDA Link 06/2022
1	somatostatin receptor 2IBA 01/2022
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 07/2021
1	N(6)-(1-iminoethyl)lysineIBA 07/2021
1	Factor Xa InhibitorsIBA 07/2021
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 07/2021
1	Thrombin FDA Link 07/2021
1	argatroban (MPQA)FDA Link 07/2021
1	NG-Nitroarginine Methyl Ester (L-NAME)IBA 07/2021
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 07/2021
1	IronIBA 03/2021

Therapy/Procedure

15	Therapeutics 07/2023 - 02/2004
5	Drug Therapy (Chemotherapy) 09/2022 - 02/2004
2	Immunotherapy 04/2024 - 12/2020
2	Glycemic Control 04/2024 - 01/2023
2	Critical Care (Surgical Intensive Care) 08/2021 - 01/2021
1	Aftercare (After-Treatment) 04/2024
1	Molecular Targeted Therapy 07/2023
1	Injections 04/2023
1	Foot Orthoses 01/2023